The U.S. pharma Sunovion has said its under-the-tongue film for Parkinson's has hit target in a late stage trial by improving motor function compared with placebo, and could be on the market next year ...

Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease Orion Corporation (“Orion”) and Criceto IKM B.V. (“Criceto”) ...

Patients should receive training on the proper use of the delivery device prior to starting treatment. The Food and Drug Administration (FDA) has approved Onapgo™ (apomorphine hydrochloride [HCl]) for ...

(RTTNews) - Supernus Pharmaceuticals, Inc. (SUPN), a biopharmaceutical company, announced on Tuesday the FDA approval of ONAPGO or apomorphine hydrochloride for the treatment of motor fluctuations in ...

Feb 4 (Reuters) - The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' (SUPN.O), opens new tab drug-device combination to treat movement-related symptoms of Parkinson's disease ...

Onapgo, a subcutaneous apomorphine infusion device, is approved for advanced Parkinson's disease, offering continuous symptom management without surgery. The TOLEDO trial showed apomorphine infusion ...

ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of ...

Parkinson’s NSW, in partnership with Local Health Districts, currently co-manage neurological nurse positions in regional areas across NSW. Parkinson’s Specialist Nurse Lauren Hogan is based in ...

Parkinson's is a neurodegenerative disorder that affects millions of people worldwide. This condition is commonly associated with ageing, as it usually affects people 65 years of age and older. But ...

Please provide your email address to receive an email when new articles are posted on . 52-week study included 85 adults with Parkinson’s and at least 3 hours/day of “off” time. At week 12, CSAI led ...

The small intestinal bacterial overgrowth (SIBO) breath test is a noninvasive test that measures the amount of gases produced by bacteria in the small intestine. Small intestinal bacterial overgrowth ...